Cargando…
Bridging the age gap: a review of molecularly informed treatments for glioma in adolescents and young adults
Gliomas are the most common primary central nervous system (CNS) tumors and a major cause of cancer-related mortality in children (age <15 years), adolescents and young adults (AYA, ages 15–39 years), and adults (age >39 years). Molecular pathology has helped enhance the characterization of th...
Autores principales: | Weiser, Annette, Sanchez Bergman, Astrid, Machaalani, Charbel, Bennett, Julie, Roth, Patrick, Reimann, Regina R., Nazarian, Javad, Guerreiro Stucklin, Ana S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533987/ https://www.ncbi.nlm.nih.gov/pubmed/37781183 http://dx.doi.org/10.3389/fonc.2023.1254645 |
Ejemplares similares
-
Response and resistance to BRAF(V600E) inhibition in gliomas: Roadblocks ahead?
por: Capogiri, Monica, et al.
Publicado: (2023) -
Treatment of NF1-Associated Optic Pathway/Hypothalamic Gliomas in Patients With Diencephalic Syndrome
por: Weiser, Annette, et al.
Publicado: (2023) -
Opinion: Bridging gaps and doubts in glioblastoma cell-of-origin
por: Jovanovich, Nicolina, et al.
Publicado: (2022) -
DIPG-09. Diffuse Midline Glioma-Adaptive Combinatory Trial (DMG-ACT): A biology-driven platform trial in pediatric and young adult patients with diffuse midline glioma
por: Franson, Andrea, et al.
Publicado: (2022) -
HGG-13. ONCOGENIC STAT3 AND SHP2 ACTIVATION IN ROS1-FUSION DRIVEN INFANT-TYPE HEMISPHERIC GLIOMAS
por: Postlmayr, Andreas, et al.
Publicado: (2023)